
SURVISC is indicated for using as a surgical aid in ophthalmic anterior segment surgery including cataract extraction, lens implantation and corneal transplantation surgery and glaucoma filtering surgery.
Trade Concentration Supply (each syringe)
Survisc® 15mg/ml 0.4ml/0.55ml/0.85ml/1.0ml
Survisc®Plus 20mg/ml 0.4ml/0.55ml/0.85ml/1.0ml
Survisc® and Survisc®Plus have obtained CE mark under MDR 2017/745.